D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
PUT
Palo Alto Networks
PANW
$259B
| $10M | 0.01% |
186,600
-786,000
| -81% | -$46.7M |
|
1252
CALL
Tilray
TLRY
$498M
| $9.96M | 0.01% |
+43,840
| New | +$10.3M |
|
1253
CALL
Amgen
AMGN
$203B
| $9.95M | 0.01% |
40,000
+37,600
| +1,567% | +$8.97M |
|
1254
Weibo
WB
$1.92B
| $9.95M | 0.01% |
+197,175
| New | +$9.94M |
|
|
ERF
1255
DELISTED
Enerplus Corporation
ERF
| $9.94M | 0.01% |
1,978,884
+909,600
| +85% | +$4.02M |
|
|
MRO
1256
PUT
DELISTED
Marathon Oil Corporation
MRO
| $9.93M | 0.01% |
930,000
+330,000
| +55% | +$3.18M |
|
1257
RB Global
RBA
$21.7B
| $9.93M | 0.01% |
169,602
-77,813
| -31% | -$4.56M |
|
|
XLRN
1258
DELISTED
Acceleron Pharma
XLRN
| $9.92M | 0.01% |
73,175
+11,226
| +18% | +$1.45M |
|
1259
MaxLinear
MXL
$5.88B
| $9.89M | 0.01% |
290,161
-463,151
| -61% | -$16.5M |
|
1260
Capri Holdings
CPRI
$1.82B
| $9.89M | 0.01% |
+193,837
| New | +$9.13M |
|
|
DISAU
1261
DELISTED
Disruptive Acquisition Corporation I Unit
DISAU
| $9.88M | 0.01% |
+1,000,000
| New | +$9.86M |
|
1262
CALL
Hilton Worldwide
HLT
$75.3B
| $9.88M | 0.01% |
81,700
+29,000
| +55% | +$3.35M |
|
1263
Synopsys
SNPS
$74.5B
| $9.87M | 0.01% |
+39,836
| New | +$10.1M |
|
1264
Fastly Inc
FSLY
$3.14B
| $9.83M | 0.01% |
146,043
-430,541
| -75% | -$37M |
|
|
BBBY
1265
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $9.82M | 0.01% |
337,000
+190,700
| +130% | +$5.34M |
|
1266
Kura Oncology
KURA
$901M
| $9.81M | 0.01% |
347,190
-233,403
| -40% | -$7.38M |
|
1267
Veracyte
VCYT
$4.44B
| $9.81M | 0.01% |
182,604
+153,978
| +538% | +$8.87M |
|
1268
Atara Biotherapeutics
ATRA
$69.5M
| $9.81M | 0.01% |
27,322
+2,936
| +12% | +$1.3M |
|
|
SV
1269
DELISTED
Spring Valley Acquisition Corp. Class A Ordinary Share
SV
| $9.8M | 0.01% |
+969,721
| New | +$10.2M |
|
1270
CALL
Cisco
CSCO
$452B
| $9.79M | 0.01% |
189,400
-34,600
| -15% | -$1.62M |
|
1271
Regeneron Pharmaceuticals
REGN
$69.9B
| $9.79M | 0.01% |
20,700
-34,958
| -63% | -$17M |
|
|
ATVI
1272
CALL
DELISTED
Activision Blizzard
ATVI
| $9.78M | 0.01% |
105,200
-25,000
| -19% | -$2.35M |
|
1273
LivePerson
LPSN
$20.8M
| $9.78M | 0.01% |
12,358
+10,668
| +631% | +$9.88M |
|
|
IRBT
1274
CALL
DELISTED
iRobot
IRBT
| $9.77M | 0.01% |
80,000
-56,600
| -41% | -$6.43M |
|
1275
Sotera Health
SHC
$4.92B
| $9.77M | 0.01% |
391,237
+351,650
| +888% | +$9.3M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.